ABSI
Price
$4.53
Change
-$0.34 (-6.98%)
Updated
Oct 17 closing price
Capitalization
677.34M
17 days until earnings call
Intraday Buy/Sell Signals
KYMR
Price
$59.83
Change
-$0.63 (-1.04%)
Updated
Oct 17 closing price
Capitalization
4.28B
11 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

ABSI vs KYMR

Header iconABSI vs KYMR Comparison
Open Charts ABSI vs KYMRBanner chart's image
Absci
Price$4.53
Change-$0.34 (-6.98%)
Volume$7.06M
Capitalization677.34M
Kymera Therapeutics
Price$59.83
Change-$0.63 (-1.04%)
Volume$698.39K
Capitalization4.28B
ABSI vs KYMR Comparison Chart in %
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. KYMR commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and KYMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (ABSI: $4.53 vs. KYMR: $59.83)
Brand notoriety: ABSI and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 123% vs. KYMR: 90%
Market capitalization -- ABSI: $677.34M vs. KYMR: $4.28B
ABSI [@Biotechnology] is valued at $677.34M. KYMR’s [@Biotechnology] market capitalization is $4.28B. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 5 TA indicator(s) are bullish while KYMR’s TA Score has 5 bullish TA indicator(s).

  • ABSI’s TA Score: 5 bullish, 4 bearish.
  • KYMR’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both ABSI and KYMR are a good buy in the short-term.

Price Growth

ABSI (@Biotechnology) experienced а +23.10% price change this week, while KYMR (@Biotechnology) price change was +4.58% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

ABSI is expected to report earnings on Nov 05, 2025.

KYMR is expected to report earnings on Oct 30, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($4.28B) has a higher market cap than ABSI($677M). ABSI YTD gains are higher at: 72.901 vs. KYMR (48.720). ABSI has higher annual earnings (EBITDA): -100.08M vs. KYMR (-267.03M). KYMR has more cash in the bank: 665M vs. ABSI (117M). ABSI has less debt than KYMR: ABSI (7.41M) vs KYMR (85.7M). KYMR has higher revenues than ABSI: KYMR (44.7M) vs ABSI (4.14M).
ABSIKYMRABSI / KYMR
Capitalization677M4.28B16%
EBITDA-100.08M-267.03M37%
Gain YTD72.90148.720150%
P/E RatioN/AN/A-
Revenue4.14M44.7M9%
Total Cash117M665M18%
Total Debt7.41M85.7M9%
TECHNICAL ANALYSIS
Technical Analysis
ABSIKYMR
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 7 days ago
83%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
89%
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
Aroon
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OIEFX25.370.16
+0.63%
JPMorgan Equity Income R2
HNCJX21.270.04
+0.19%
Hartford International Growth I
MTINX22.650.04
+0.18%
NYLI Income Builder Investor Class
FITFX16.61N/A
N/A
Fidelity Flex International Index
RYVFX10.22-0.01
-0.10%
Royce Small-Cap Value Service

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
-6.98%
RXRX - ABSI
65%
Loosely correlated
-7.86%
CRSP - ABSI
59%
Loosely correlated
+1.05%
BEAM - ABSI
55%
Loosely correlated
+0.74%
ABCL - ABSI
54%
Loosely correlated
-4.28%
NTLA - ABSI
47%
Loosely correlated
-0.64%
More

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with NRIX. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.04%
NRIX - KYMR
65%
Loosely correlated
-1.89%
VERA - KYMR
60%
Loosely correlated
+2.36%
NUVL - KYMR
56%
Loosely correlated
+2.32%
CGON - KYMR
55%
Loosely correlated
-0.93%
IDYA - KYMR
54%
Loosely correlated
+5.67%
More